The caveats: About 40,000 Americans are newly infected every year. And HIV infection is still among the top 10 leading causes of death among Americans between the ages of 25 and 44.
The caveats: It is difficult to study. The strongest evidence is for palliative care in hospitals.
The caveats: Recent research says the evidence for improved outcomes was of moderate quality. And VBID still hasn’t proved its mettle as a cost saver.
The caveat: The prices are now falling for various reasons, but the high cost still means many who might benefit don’t have access to the medications.